RED BANK GROUP PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: P83603 | MANCHESTER, M26 2SP
Showing results 51-100 of 597
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Promethazine hydrochloride | 964 | 125.8K | £9.2K | +169.7% ▲ |
| Other emollient preparations | 953 | 546.9K | £6.8K | +58.7% ▲ |
| Naproxen | 928 | 49.1K | £1.6K | -6.0% ▼ |
| Glucose blood testing reagents | 921 | 71.3K | £11.7K | +16.7% ▲ |
| 904 | 507.8K | £6.4K | -8.1% ▼ | |
| Lisinopril | 896 | 32.4K | £728 | -18.2% ▼ |
| Senna | 893 | 52.0K | £1.2K | +48.4% ▲ |
| Canagliflozin | 887 | 25.9K | £32.2K | +517.8% ▲ |
| Alendronic acid | 879 | 3,864 | £1.4K | +17.2% ▲ |
| Gliclazide | 873 | 60.7K | £1.5K | +2.6% ▲ |
| Alginic acid compound preparations | 867 | 530.6K | £5.2K | +48.0% ▲ |
| Candesartan cilexetil | 850 | 28.1K | £1.4K | -28.4% ▼ |
| 844 | 880 | £39.1K | +171.7% ▲ | |
| Thiamine hydrochloride | 828 | 54.6K | £1.3K | +57.1% ▲ |
| Warfarin sodium | 822 | 55.4K | £1.9K | +74.3% ▲ |
| Quetiapine | 816 | 31.0K | £6.2K | +31.1% ▲ |
| Codeine phosphate | 751 | 82.0K | £2.8K | +4.5% ▲ |
| Finasteride | 730 | 23.3K | £820 | +11.5% ▲ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 722 | 95.8K | £5.6K | +301.8% ▲ |
| Bendroflumethiazide | 697 | 26.0K | £416 | -9.9% ▼ |
| Carbocisteine | 691 | 115.4K | £2.8K | +29.4% ▲ |
| Lamotrigine | 681 | 40.7K | £4.4K | +15.3% ▲ |
| 674 | 1,366 | £48.0K | +23.7% ▲ | |
| Zopiclone | 670 | 12.0K | £507 | +21.0% ▲ |
| Morphine sulfate | 650 | 96.2K | £4.1K | -0.9% vs avg |
| Semaglutide | 640 | 12.9K | £50.3K | +165.8% ▲ |
| Lactulose | 630 | 431.5K | £4.0K | +91.4% ▲ |
| Memantine hydrochloride | 629 | 22.4K | £3.6K | +90.4% ▲ |
| Hydrocortisone | 627 | 22.0K | £2.9K | +39.8% ▲ |
| Ibuprofen | 626 | 65.0K | £1.5K | +23.1% ▲ |
| Spironolactone | 616 | 16.7K | £1.7K | +14.3% ▲ |
| Empagliflozin | 612 | 17.9K | £22.2K | -2.2% ▼ |
| Sildenafil (Erectile Dysfunction) | 586 | 3,835 | £531 | +16.3% ▲ |
| Flucloxacillin sodium | 585 | 26.6K | £1.4K | +30.1% ▲ |
| Tiotropium bromide | 577 | 5,148 | £14.3K | +89.8% ▲ |
| Insulin aspart | 575 | 2,989 | £20.3K | +51.0% ▲ |
| Doxycycline hyclate | 572 | 8,107 | £784 | +11.6% ▲ |
| Edoxaban | 568 | 16.4K | £27.2K | -18.9% ▼ |
| Digoxin | 563 | 16.4K | £1.2K | +48.8% ▲ |
| Buprenorphine | 562 | 2,400 | £8.7K | +53.4% ▲ |
| Nitrofurantoin | 561 | 7,753 | £3.8K | +17.6% ▲ |
| Alogliptin | 557 | 16.1K | £14.5K | +119.6% ▲ |
| Perindopril erbumine | 553 | 18.7K | £1.4K | +4.2% ▲ |
| Bumetanide | 551 | 25.8K | £2.5K | +102.3% ▲ |
| Ranolazine | 538 | 28.2K | £5.5K | +216.6% ▲ |
| Desogestrel | 532 | 72.6K | £3.1K | +34.2% ▲ |
| Felodipine | 520 | 19.4K | £1.7K | -12.4% ▼ |
| Duloxetine hydrochloride | 517 | 17.8K | £1.3K | -18.7% ▼ |
| Mebeverine hydrochloride | 514 | 40.7K | £1.5K | +65.5% ▲ |
| Tirzepatide | 508 | 508 | £48.6K | +161.6% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.